About US
Contact us
-
US hospitals turning to gray-market vendorsHalf of US hospitals are turning to gray-market vendors as the country's drug shortage continues, a new survey has shown. The Institute for Safe Medication Practices (ISMP) has issued a safety aler2011/8/31
-
Pfizer receives FDA approval of XALKORI for ALK-positive NSCLCPfizer Inc. has received FDA approval of XALKORI® (crizotinib) capsules - the first and only therapy specifically for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC2011/8/30
-
Researchers identify molecule that can stop the formation of amyloid fibrilsA molecule which can stop the formation of long protein strands, known as amyloid fibrils, that cause joint pain in kidney dialysis patients has been identified by researchers at the University of Lee2011/8/29
-
Pfizer, Abbott receive FDA approval for Xalkori, Vysis ALK FISH test to treat NSCLCThe U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express th2011/8/29
-
SFDA Deputy Commissioner Wu Zhen meets the delegation of MHLWOn the morning of August 23, 2011, Wu Zhen, Deputy Commissioner of the State Food and Drug Administration (SFDA), met with the visiting delegation headed by Dr. Yoshinobu Hirayama, Councilor for Pharm2011/8/26
-
Simcere receives Chinese SFDA approval for Iremod to treat active rheumatoid arthritisSimcere Pharmaceutical Group ("Simcere" or the "Company") (NYSE: SCR), a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary2011/8/26
-
Removal of OTC drugs for toddlers from the market reduces therapeutic errorsA new study by researchers at the University of Maryland has revealed a 46 percent drop in reported errors after drugmakers in October 2007 removed from the market a number of over-the-counter cough a2011/8/26
-
UK announces largest-ever research investmentThe UK Government has announced five-year funding worth £800m for research into diagnosis, prevention and treatment, the nation's largest-ever investment into early-stage health research. The2011/8/25
-
The British Pharmacopoeia 2012 is Now AvailableSO (The Stationery Office), on behalf of the British Pharmacopoeia Secretariat of the Medicines and Healthcare products Regulatory Agency (MHRA), has just published the British Pharmacopoeia (BP) 20122011/8/24
-
Prescription drug shortages forcing docs, pharmacists to scramblexperts say shortage of certain hospital drugs has become a major crisis. San Francisco Chronicle: Critical Drugs In Short Supply Record shortages of prescription drugs in the United States are fo2011/8/24